Skip to main content
SpringerLink
Log in

Lymphokines and soluble interleukin-2 receptors in juvenile chronic arthritis

Clinical and laboratory correlations

  • Originals
  • Published:
Rheumatology International Aims and scope Submit manuscript

Summary

Serum levels of interleukin (IL)-2, interferon gamma (IFNg) and soluble IL-2 receptors (sIL-2R) were determined in sera from 34 patients with poly-or pauciarticular juvenile chronic arthritis (JCA) by use of enzyme-linked immunosorbent assays (ELISAs). Levels of sIL-2R were elevated in the group of patients compared with those of healthy children and correlated significantly with several parameters of clinical activity, including the functional capacity, joint score, visual-analogue score and erythrocyte sedimentation rate (ESR). Serum IL-2 levels were also elevated in the JCA patients, correlating with the patients functional capacity. Serum levels of IFNg were below the detection limit of the assay. Our data supported the notion that T-cell activation plays a role in the immunopathologic processes leading to clinical JCA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Silverman ED, Somma C, Khan MM, Melmon KL, Engleman GE (1990) Abnormal T suppressor cell function in juvenile rheumatoid arthritis. Arthritis Rheum 33:205–211

    Google Scholar 

  2. Tsokos GC, Mavridis A, Inghiramin G, Pillemer SR, Emery HM, Magilavy DB (1987) Cellular immunity in patients with systemic juvenile rheumatoid arthritis. Clin Immunol Immunopathol 42:86–92

    Google Scholar 

  3. Tsokos GC, Inghirami G, Pillemer SR, Mavridis A, Magilavi DB (1988) Immunoregulatory aberations in patients with polyarticular juvenile rheumatoid arthritis. Clin Immunol Immunopathol 47:62–74

    Google Scholar 

  4. Oen K, Wilkins JA, Krzekotowska D (1985) OKT4:OKT8 ratios of circulating T cells and in vitro suppressor cell function of patients with juvenile rheumatoid arthritis. J Rheumatol 12:321–327

    Google Scholar 

  5. Barron KS, Decunto CL, Montalvo JF, Orson FM, Lewis DE (1989) Abnormalities of immuneregulation in juvenile rheumatoid arthritis. J Rheumatol 16:940–948

    Google Scholar 

  6. Martini A (1987) Immunological abnormalities in juvenile rheumatoid arthritis. Scand J Rheumatol [Suppl] 66:107–118

    Google Scholar 

  7. Permin H, Hørbov S, Wiik A, Vestergaard JK (1978) Antinuclear antibodies in juvenile chronic arthritis. Acta Paediatr Scand 67:181–185

    Google Scholar 

  8. Bendtzen K (1988) Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity. Immunol Lett 19:183–192

    Google Scholar 

  9. Kroemer G, Wick G (1989) The role of interleukin 2 in autoimmunity. Immunol Today 10:246–251

    Google Scholar 

  10. Rubin LA (1990) The soluble interleukin-2 receptor in rheumatic disease. Arthritis Rheum 33:1145–1147

    Google Scholar 

  11. Kvien TK, Høyerall HM, Kåss E (1982) Diagnostic criteria of rheumatoid arthritis in children. Proposed criteria for controlled clinical studies. Scand J Rheumatol 11:187–192

    Google Scholar 

  12. Kvien TK, Høyeraal HM, Sandstad B (1982) Assessment methods of disease activity in juvenile rheumatoid arthritis-evaluated in a prednisolone/placebo double-blind study. J Rheumatol 9:696–702

    Google Scholar 

  13. Steinbrocker, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659–662

    Google Scholar 

  14. Humbel R, Kadusch P (1985) Use of HEp-2 cells in the IF test for detection of antinuclear antibodies. Protides of the biological fluids. Pergamon, Oxford

    Google Scholar 

  15. Høier-Madsen M, Andersen V, Glarborg M (1980) Mikroag-glutinationstest til undersøgelse for antistoffer mod extractable nuclear antigen (ENA). Sammenligmende undersøgelse af forskellige patientgrupper for ANA, DNA og ENA antistoffer. Ugeskr Laeger 142:2627–2630

    Google Scholar 

  16. Fomsgaard A, Worsaae H, Bendtzen K (1988) Detection of tumour necrosis factor from lipopolysaccharide-stimulated human mononuclear cells by enzyme-linked immunosorbent assay and cytotoxicity bioassay. Scand J Immunol 27:143–147

    Google Scholar 

  17. Keystone EC, Snow KM, Bombardier C, Chang CH, Nelson DL, Rubin LA (1988) Elevated soluble interleukin-2 receptor level in the sera and synovial fluids of patients with rheumatoid arthritis. Arthritis Rheum 31:844–849

    Google Scholar 

  18. Campen DH, Horwitz DA, Quismoti FP, Ehresman GR, Martin WJ (1988) Serum levels of interleukin-2 receptor and activity of the rheumatic diseases characterized by immune system activation. Arthritis Rheum 31:1358–1364

    Google Scholar 

  19. Wood NC, Symons JA, Duff GW (1988) Serum interleukin-2 receptors in rheumatoid arthritis: a prognostic indicator of disease activity? J Autoimmunity 1:353–360

    Google Scholar 

  20. Symons JA, Wood NC, DiGiovine FS, Duff GW (1988) Soluble IL-2 receptor in rheumatoid arthritis: correlation with disease activity and IL-2 inhibition. J Immunol 141:2612–2618

    Google Scholar 

  21. Wolf RE, Bredford WG (1988) Soluble interleukin-2 receptors in systeic lupus erythematosus. Arthritis Rheum 31:729–735

    Google Scholar 

  22. Tokano Y, Murashima A, Takasaki Y, Hashimoto H, Okomura K, Mirose S (1989) Relation between soluble IL-2 receptor and clinical findings in patients with systemic lupus erythematosus. Ann Rheum Dis 48:803–809

    Google Scholar 

  23. Wolf RE, Baethge BA (1990) Interleukin-1α, interleukin-2, and soluble interleukin-2 receptors in polymyositis. Arthritis Rheum 33:1007–1014

    Google Scholar 

  24. Degiannis D, Seibold JR, Czarnecki M, Raskova J, Raska K (1990) Soluble interleukin-2 receptors in patients with systemic sclerosis. Arthritis Rheum 33:375–380

    Google Scholar 

  25. Famularo G, Procopio A, Giacomelli R (1990) Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis. Clin Exp Immunol 81:368–372

    Google Scholar 

  26. Førre Ø, Dobloug JH, Natvig JB (1982) Augmented numbers of HLA-DR-positive T lymphocytes in the synovial fluid and synovial tissue of patients with rheumatoid arthritis and juvenile rheumatoid arthritis. Scand J Immunol 15:227–231

    Google Scholar 

  27. Huang YP, Perrin LH, Miescher PA, Zubler RH (1988) Correlation of T and B cell activities in vitro and IL-2 levels in systemic lupus erythematosus. J Immunol 141:827–833

    Google Scholar 

  28. Trotter JL, Clifford DB, Anderson CB (1988) Elevated serum interleukin-2 levels in chronic progressive multiple sclerosis. N Engl J Med 318:1206

    Google Scholar 

  29. Emery P, Williamson DJ, Mackay IR (1987) The role of cytokines in rheumatological inflammation. Concepts in immunology, vol 4. Autoimmunoregulation and autoimmune disease. Karger, Basel

    Google Scholar 

  30. Oen K, Warrington R, Rosenberg AM, Krzekotowska D (1988) IL-2 production in autologous mixed lymphocyte reaction of patients with juvenile rheumatoid arthritis. Clin Exp Immunol 74:87–93

    Google Scholar 

  31. Miller JM, Olds L (1987) Interleukin-2 production by lymphocytes from blood of children with arthritis is less suppressed than in systemic lupus or cystic fibrosis. J Rheumatol 14:736–739

    Google Scholar 

  32. Martini A, Ravelli A, Notarangelo LD, Macario R, Lanfranchi A, Rondena D, Ugazio AG, Burgio R (1986) Enhanced interleukin 1 and depressed interleukin 2 production in juvenile arthritis. J Rheumatol 13:598–603

    Google Scholar 

  33. Bacon TH, De Verre-Tyndall A, Tyrrel A, Denman AM, Ansell BM (1983) Interferon system in patients with systemic juvenile chronic arthritis: in vivo and in vitro studies. Clin Exp Immunol 54:23–30

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Medical Immunology, Medical Department TTA, Rigshospitalet State University Hospital, Tagensvej 20, DK-2200, Copenhagen, Denmark

    K. Müller & K. Bendtzen

  2. Pediatric Department GGK, Rigshospitalet State University Hospital, Tagensvej 20, DK-2200, Copenhagen, Denmark

    F. Karup Pedersen

  3. Laboratory of Autoimmune Serology, State Serum Institute, DK-2200, Copenhagen, Denmark

    A. Wiik

Authors
  1. K. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Karup Pedersen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Wiik
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Bendtzen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Müller, K., Karup Pedersen, F., Wiik, A. et al. Lymphokines and soluble interleukin-2 receptors in juvenile chronic arthritis. Rheumatol Int 12, 89–92 (1992). https://doi.org/10.1007/BF00290260

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00290260

Key words

Search

Navigation